I would make a bet that as surgeons get familair with Novosorb they probably will be trying it out on lower limb ulcers. Not as good as doing a trial and publishing it, but if they get success they will keep on using it.
PNV Media Thread, page-3235
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.47 |
Change
0.120(5.11%) |
Mkt cap ! $1.692B | |||
| Open | High | Low | Value | Volume |
| $2.38 | $2.52 | $2.38 | $3.499M | 1.419M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 26578 | $2.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.47 | 9308 | 23 |
View Market Depth
| Last trade - 12.44pm 10/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |